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Abstract
Background:  Recombinant protein expression in mammalian cells is mostly achieved by stable
integration of transgenes into the chromosomal DNA of established cell lines. The chromosomal
surroundings have strong influences on the expression of transgenes. The exploitation of defined loci by
targeting expression constructs with different regulatory elements is an approach to design high level
expression systems. Further, this allows to evaluate the impact of chromosomal surroundings on distinct
vector constructs.
Results: We explored antibody expression upon targeting diverse expression constructs into previously
tagged loci in CHO-K1 and HEK293 cells that exhibit high reporter gene expression. These loci were
selected by random transfer of reporter cassettes and subsequent screening. Both, retroviral infection and
plasmid transfection with eGFP or antibody expression cassettes were employed for tagging. The tagged
cell clones were screened for expression and single copy integration. Cell clones producing > 20 pg/cell
in 24 hours could be identified. Selected integration sites that had been flanked with heterologous
recombinase target sites (FRTs) were targeted by Flp recombinase mediated cassette exchange (RMCE).
The results give proof of principle for consistent protein expression upon RMCE. Upon targeting antibody
expression cassettes 90-100% of all resulting cell clones showed correct integration. Antibody production
was found to be highly consistent within the individual cell clones as expected from their isogenic nature.
However, the nature and orientation of expression control elements revealed to be critical. The impact
of different promoters was examined with the tag-and-targeting approach. For each of the chosen
promoters high expression sites were identified. However, each site supported the chosen promoters to
a different extent, indicating that the strength of a particular promoter is dominantly defined by its
chromosomal context.
Conclusion:  RMCE provides a powerful method to specifically design vectors for optimized gene
expression with high accuracy. Upon considering the specific requirements of chromosomal sites this
method provides a unique tool to exploit such sites for predictable expression of biotechnologically
relevant proteins such as antibodies.
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Background
High level expression of proteins from mammalian cells is
crucial for diverse questions in basic research such as
structure analysis and is a key issue for biopharmaceutical
production. The current state of the art for establishment
of recombinant protein production cell lines relies on
transfection of producer cells with a plasmid that encodes
the gene of interest driven by a potent promoter. Upon
uptake into the nucleus, the incoming DNA, in particular
through double-strand breaks, is sensed by the cellular
repair machinery. These enzymes stably integrate the
incoming recombinant DNA into the cellular DNA by ille-
gitimate recombination. This procedure is largely random
and accordingly, the sites of integration are mostly spread
all over the genome [1].
Once integrated into the cellular DNA, the transgene cas-
sette is affected by neighboring chromosomal elements
that modulate the promoter to a high extent (see West and
Fraser, [2] for a recent review). Enhancers and silencers
directly affect promoters in cis and may be shielded by
insulators. Beside this, chromatin modeling elements
such as locus control regions and S/MARs significantly
influence the transgene expression level [2-4]. Finally, evi-
dence has been provided that also nearby/close promoter
elements interact with incoming promoters (promoter
crosstalk) and can result in their downregulation (so-
called promoter occlusion) or potentiation [5]. Thus,
upon random integration, individual cell clones display a
highly heterogenous expression pattern and have to be
screened for appropriate expression.
Homologous recombination is used in stem cells for tar-
geting transgene to specific loci. In differentiated cells
homologous recombination is very infrequent. Recently,
Zn-finger nuclease based approaches have been designed
for targeting transgene cassettes in mammalian cells to
defined loci (reviewed in [6,7]). Thus, tools are available
to target individual chromosomal sites for various appli-
cations in order to overcome the limitations of random
integrations. While such methods are useful for gene ther-
apies and basic research, their value for protein expression
is limited since chromosomal sites in production cell lines
that support high level recombinant protein expression
are usually not known.
Indeed, in order to meet the requirements for high and
stable protein expression extensive screenings are per-
formed to identify those cell lines that provide optimal
protein production. For industrial purposes devices for
robotic cell and sample propagation were developed that
support high throughput screenings of millions of indi-
vidual cell clones, thereby allowing the identification of
those cell clones with favorable expression of the trans-
gene. Beside this, procedures for enhancing the copy
number of transgene integrations by gene amplification
have been employed (see e.g. [8,9]). However, high clone
to clone variations as well as instability in expression lev-
els have been found. The latter is due to genetic rearrange-
ments during gene amplification as well as to the
emergence of drug-resistance [10-12]. Although these pro-
cedures have provided potent producer clones, the pitfalls
are obvious: for any and every new protein and/or expres-
sion construct the screening process has to be re-estab-
lished which is both time consuming and expensive.
Alternative methods to decrease the production cost and
the time needed for cell line development are thus essen-
tial.
In the last two decades specific genetic engineering of
mammalian cells via site specific recombinases such as
Cre and Flp has been explored. These recombinases spe-
cifically bind and recombine short recombination target
sites, the 34 bp loxP site and 48 bp FRT site, respectively.
Once a chromosomal site in the host genome is tagged
with a single recombination target sequence, the recombi-
nases mediate site specific targeting of plasmids carrying
the same recombination target site. Thereby, targeted inte-
gration of whole plasmids into pre-tagged integration
sites in mammalian cells is feasible [12,13]. This first gen-
eration gene targeting strategy suffers from low efficiency
due to possible excision of the integrated cassette and also
from integration of extended plasmid backbone
sequences. Accordingly, only few cell lines have been pro-
vided so far that allow for successful targeted integration
of a transgene cassette. Although some tagged cell lines are
commercially available, they are not screened for high
production and do not meet the requirements for many
applications.
The method of recombinase mediated targeting was sig-
nificantly improved by flanking an initial tagging cassette
with a set of non-interacting recombinase recognition
sites. Upon integration, such cassettes can be precisely
exchanged for an incoming vector that is flanked with the
same set of recombinase recognition sites [13-15]. Hence,
the term recombinase mediated cassette exchange
(RMCE) was coined [16]. Basically, RMCE relies on two
heterologous recombinase target sites (spacer mutants)
that resist site specific recombination between each other
but still undergo recombination with their respective
homologous counterparts. Mutants that can be exploited
in this respect have been identified both for the Flp [14]
and the Cre system (reviewed in [17]). The main advan-
tage of RMCE is the lack of excision which reduces the tar-
geting efficiency in simple first generation targeted
integration approaches. Upon implementation of strin-
gent selection strategies the frequency of targeting can be
increased [18] even up to 100% [19,20]. Further, RMCE
overcomes the integration of bacterial vector sequencesBMC Biotechnology 2009, 9:100 http://www.biomedcentral.com/1472-6750/9/100
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which potentially limits mammalian gene expression.
Meanwhile, this technology has been exploited in various
cell systems and for various applications including the
establishment of viral producer cells [20,21], EPO produc-
tion [22], and for the evaluation of vector design [19] (see
[17] for a recent review).
A systematic exploitation of defined chromosomal sites
for expression of proteins has not yet been followed. The
present study focuses on the evaluation of different
approaches for tagging and the evaluation of the flexibil-
ity of incoming cassettes concerning the predictability of
expression upon targeting. Moreover, we give evidence
that the strength of a given promoter is strongly linked to
the properties of the respective chromosomal integration
site. Together, the study gives new insights in the interac-
tions between promoters and chromosomal elements.
Thereby, it contributes to a deeper understanding of these
mechanisms which is a prerequisite for a systematic
exploitation of chromosomal integration sites for various
applications including protein production.
Methods
Plasmids
The retroviral tagging cassette RV-GFP has been described
elsewhere ('pTAGeGFP' in [20]). It contains in its 3'LTR a
wild-type FRT site and a F5 spacer mutant FRT site, fol-
lowed by an ATG-deleted neomycin phosphotransferase
gene.
Plasmidic tagging cassettes P-HTG and P-GFP harbor the
respective reporter gene(s) flanked by a wild-type FRT site
and F5 spacer mutant FRT site, and are also followed by an
ATG-deficient neomycin phosphotransferase gene. In P-
GFP eGFP as fluorescence marker is expressed from the
SV40 promoter, in P-HTG the PGK promoter drives the
HTG fusion protein comprising hygromycin phospho-
transferase, thymidine kinase and eGFP. The antibody
coding tagging cassette harbors the SV40 driven HTG
fusion and the heavy and the light chain of an IgG mole-
cule each controlled independently by an SV40 promoter/
enhancer.
Targeting cassettes contain the FRT wild-type and the F5
FRT mutant site flanking an antibody expression unit. The
design of the cassettes is depicted in the individual figures.
The cassettes carry the SV40 promoter, the CMV promoter,
a hybrid promoter comprising the MPSV enhancer ele-
ments and the CMV promoter [23] or a bidirectional pro-
moter composed of the Adenovirus major late gene
promoter and the elongation factor 1 promoter [24]. Tar-
geting vectors encode RFP, eGFP or antibody expression
cassettes. In all targeting vectors, the PGK promoter or an
IRES element and an ATG start codon is positioned
upstream of the FRT mutant site to complement the inac-
tive neoR gene after targeting. Maps or sequences are avail-
able upon request.
Mammalian Cell Culture and Transfection
CHO-K1 cells (ATCC CCL 61) were cultivated at 37°C in
a humidified atmosphere with 7.5% CO2 in CD Hybrid-
oma medium (Gibco) with 2% fetal calf serum (Biowest),
8 mM L-glutamine and 4 ml of 250× Cholesterol lipid
concentrate (Gibco) per litre medium. Selection was per-
formed in medium supplemented with hygromycin B
(150 U/ml), G418 (500 μg/ml) or ganciclovir (10 μg/ml).
HEK293 cells (BioReliance) were cultivated at 37°C in a
humidified atmosphere with 5% CO2 in DMEM (Gibco)
with 10% fetal calf serum (Cytogen), 2 mM L-glutamine,
penicillin (10 U/ml) and streptomycin sulfate (100 μg/
ml). Selection was performed in medium supplemented
with hygromycin B (200 U/ml), G418 (1500 μg/ml) or
ganciclovir (10 μg/ml).
For plasmidic transfer CHO-K1 cells were transfected with
4 μg of the tagging vector using the nucleofection standard
protocol (amaxa AG; Cologne; Germany; Nucleofector™
Kit V) and selected with hygromycin B for optimal gener-
ation of single copy clones. HEK293 cells were plasmid
transfected using the GenePulser electroporator (BioRad).
For this purpose 1 × 106 cells were transfected with 2.6 μg
of the tagging vector carrying an eGFP cassette. eGFP pos-
itive cells were sorted using flow cytometry and individual
clones were expanded. Retroviral tagging was performed
as described earlier [19]. In brief, tagging viral vectors were
generated upon transfection of PG13 packaging cells. The
supernatant was used to infect HEK293 and CHO-K1 cells
at an m.o.i. of 0.1 and the cells were subjected to selection
with hygromycin B.
Targeted Cassette Exchange
For site-specific cassette exchange 4 × 105  of tagged
HEK293 cells were co-transfected with 2 μg Flp recombi-
nase-expressing vector (pFlpe [20]) and 2 μg of targeting
plasmid using lipofection (GenePORTER™ 2 Transfection
Reagent, Peqlab). Targeting of tagged CHO-K1 cells was
performed using nucleofection (amaxa) by cotransfer of 4
μg Flp recombinase-expressing vector and 1 μg of the tar-
geting plasmid. For both, the medium was replaced 24 h
post transfection and the cells were cultivated for 4 days to
allow cassette exchange. On the fifth day the cells were
transferred to a 60-mm culture plate and G418- and gan-
ciclovir-containing medium to select for targeted daughter
clones.
PCR Analysis
Neo-resistant clones were checked for correct integration
of the targeting vector by PCR. The use of a set of primers
where the 5' primer is located in the newly integrated tar-
geting cassette (e.g. the IRES element or PGK promoter)BMC Biotechnology 2009, 9:100 http://www.biomedcentral.com/1472-6750/9/100
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and the 3' primer located in the tagging backbone (e.g. the
neomycin phosphotransferase gene) leads to the amplifi-
cation of a targeting-specific product. The PCR is per-
formed using the Mango-Taq Polymerase Kit (Bioline).
The annealing temperature of the used primers (e.g.
primer pair: PGKfwd 5' TCTCGCACATTCTTCACGTCC 3'
and Neorev2 5' GTCATAGCCGAATAGCCTCTCC-3') was
58°C with an elongation time of 30 sec.
Flow Cytometry
FACSCalibur and FACSVantage SE (Becton Dickinson)
were used for evaluation and isolation of eGFP positive
cells. The cells were washed, trypsinized and stained with
propidium iodide (50 μg/ml) to exclude dead cells from
the analysis.
ELISA
The specific productivity of the clones was analysed by
sandwich enzyme linked immunosorbent assay (ELISA).
The cells were seeded on a 6-well plate with a density of 5
× 105 cells and incubated for 24 h with 2 ml of medium.
The next day the cell number was determined, the super-
natant harvested and centrifuged (5 min for 1000 rpm)
and added to a 96-well plate covered with an Fc-specific
anti-human IgG (SIGMA). The photometric measurement
was done based on a substrate conversion by peroxidase
(HRPO) labelled goat anti human IgG (H+L), (CALTAG™
Laboratories). Levels significantly above background and
below 0.1 pg per cell in 24 h (pcd) are indicated as 0.01-
0.1.
Results
Strategies for generation of targetable cell clones
To generate cell clones which are suitable for targeted inte-
gration we followed a Flp recombinase based strategy as
outlined in Figure 1A. It comprises the tagging of chromo-
somal integration sites within the host genome of a given
cell line with a reporter gene cassette. Catalyzed by the Flp
recombinase that is encoded by a plasmid and is co-trans-
ferred together with the targeting vector cassette exchange
will occur (Flp recombinase mediated cassette exchange,
RMCE, Figure 1A).
To generate high producer cell clones, different
approaches for tagging chromosomal loci were evaluated
(Figure 1A). We employed plasmid transduction, in par-
ticular a classical electroporation protocol for HEK293
cells and nucleofection which has been the method of
choice for many cell lines including CHO [25]. Further,
retroviral transduction was followed for both cell lines for
two reasons: first, this methodallows to statistically adjust
the copy number by using a low, defined ratio of recom-
binant virus particles to the number of infected cells (mul-
tiplicity of infection). Second, this method has been
reported to favour high expression integration sites
[26,27]. As recipients we used HEK293 and CHO-K1,
both cell lines used in basic research and industrial bio-
technology.
All tagging vectors include an expression unit encoding
eGFP, either as a fusion protein with the hygromycin
phosphotransferase/thymidine kinase (HTG) or as a sin-
gle protein unit (GFP), allowing a fluorescence-based
screening for the expression of the tagging cassette (see
Figure 1B). Identification of high expression cell clones
(screening) was either carried out by multiple rounds of
FACS sorting or limited dilution cloning steps.
Expression strength, stability and copy number of tagged 
cell clones
We comparatively evaluated the different methods for
their capability to identify high expression cell clones
from both cell lines. CHO-K1 and HEK293 cells were
tagged with an eGFP reporter cassette according to Figure
1. GFP expression of representative CHO-K1 and HEK293
master cell clones for each gene transfer method is
depicted in Figure 2A. In all these cell clones, eGFP expres-
sion was found to be stable for more than 6 months. In an
independent approach, CHO-K1 cells were tagged with an
antibody expressing construct. Cells tagged with antibody
expression constructs were cloned into 96 well plates after
selection of hygromycin resistance and then tested for
antibody expression by ELISA and for GFP by FACS. After
intensive screening of > 800 hygromycin-resistant clones,
about twenty clones were identified producing more than
2 pg per cell in 24 h (pcd), which was considered an arbi-
trary threshold for high expression. High expressing cell
clones were also analysed for their expression stability
over time. This revealed that the highest expressing clones
#6 and #8, producing 12.0 and 22.5 pcd, respectively,
showed long term instability. Although not being consid-
ered for RMCE, clone #8 gives evidence that high level
expression can be obtained from single copy integrations.
The eGFP and antibody expressing cell clones were ana-
lyzed by Southern Blot for the copy numbers of the
respective tagging construct (additional file 1). This
proved single copy integrations in clones #3, #8 and #11.
We further evaluated the frequency of single copy integra-
tions with the various tagging methods. In agreement with
previous studies classical electroporation protocols [28],
but also nucleofection provided high efficiencies of single
copy integration events (Table 1). The single copy integra-
tion rates obtained were about 30% for CHO and 56% for
HEK293 cells after plasmidic transfer. As expected, a very
high frequency (> 90%) of single copy integration events
was achieved for retrovirally tagged cell lines. Thus, all
chosen transduction protocols turned out to be suitable
for efficient tagging according to the RMCE strategy. Suc-BMC Biotechnology 2009, 9:100 http://www.biomedcentral.com/1472-6750/9/100
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cessfully tagged single copy cell clones from the various
strategies providing long term expression stability are
called "master cell clones" henceforth. They were used for
further evaluation of the targeting accuracy as well as the
homogeneity of expression upon targeting.
Targeting efficiency and specificity
We evaluated the efficiency and accuracy of RMCE upon
targeting various eGFP and antibody expressing vectors
specified in more detail below. All vectors carried an IRES
element or a promoter as illustrated in Figure 1A and were
co-transfected into the tagged master cell lines that had
Strategy for the identification of single copy tagged high expressing cell clones for cassette exchange Figure 1
Strategy for the identification of single copy tagged high expressing cell clones for cassette exchange. (A) High 
expression chromosomal loci were tagged with either retrovirally or plasmid-mediated transduced expression cassettes. These 
cassettes were flanked by a set of heterospecific recombinase target sites. Tagged cells lines were analyzed for the stable inte-
gration of one single copy of the respective tagging vector and screened for high expressing integration loci. The transfer of a 
targeting vector carrying the same heterospecific recombinase target sites as the tagging vector in presence of the Flp-recom-
binase leads to a site-specific cassette exchange. The selection for successfully targeted clones was performed by complement-
ing a silent, ATG-defective neomycin resistance gene pre-integrated upon tagging. This renders successfully targeted cells 
resistant to G418. For this purpose, the incoming targeting vector carried next to its gene of interest (antibody expression 
unit) a specific sequence (P/I) that facilitates expression of the neomycin resistance gene. (B) The vectors used for tagging are 
depicted. All tagging cassettes contain a promoter or internal ribosomal entry site for activation of the neomycin resistance 
gene and are flanked by heterospecific (Fwt-F5) FRT sites. Retroviral tagging was performed as described in [20] with a vector 
that transduces a bicistronic cassette of eGFP and a hygromycin phosphotransferase/thymidine kinase fusion protein. For plas-
midic tagging vectors with different reporter genes (eGFP and/or antibody expression unit) as well as varying promoter ele-
ments (SV40/PGK) were employed. All tagging vectors express eGFP, either as a fusion protein with the hygromycin 
phosphotransferase/thymidine kinase or as a single protein, allowing fluorescence-based screening for the expression of the 
tagging cassette.
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proven to stably express their reporter gene from a single
copy locus. The selection of successfully targeted cells was
accomplished as shown in Figure 1A. The efficiency of
integrating targeting vectors into the preselected chromo-
somal sites was evaluated. The complementation of the
defective neomycin resistance gene resulting in G418
resistant cell clones (Figure 1) was taken as a measure for
the targeting efficiency. Resistant daughter cell clones
were expanded for further analysis. Successfully targeted
master cell clones should have lost the parental construct
and show correct site-specific integration of the targeting
cassette. Figure 3 demonstrates the loss of eGFP expres-
sion after exchange with an antibody encoding cassette in
representative HEK293 and CHO-K1 daughter cell clones.
Specific integration into the previously tagged locus was
confirmed by PCR analysis as exemplified in Figure 3B.
We also proved the specifically targeted cell clones for
absence of additional random integration events of the
targeting construct by PCR or Southern Blot analysis (see
additional file 1). In Table 2, the overall targeting effi-
ciency is given as the percentage of correctly targeted
within the obtained G418-resistant clones. All HEK293
G418-resistant derived clones (daughter clones) analysed
showed the specific integration of the targeting construct
Characterization of the tagged integration sites Figure 2
Characterization of the tagged integration sites. (A) GFP expression pattern of single copy HEK293 and CHOK1 clones 
obtained upon retroviral and plasmidic transfer of the tagging cassette. Representative clones are shown. Green lines: tagged 
clones. Grey lines represent non-transfected HEK293 and CHOK1 cells, respectively. (B) CHO cells were tagged with an anti-
body expression construct. The antibody expression level production was evaluated. Only cell clones that produced >2 pcd 
are shown; the data were obtained from 3-5 replicates. Clones showing single copy integration events (data not shown) are 
marked by asterisks. Their GFP expression profile is given presented on the right. Green lines: tagged clones; grey lines: non-
transfected CHOK1 cells. Nomenclature: HRV-GFP: HEK293 cells retrovirally tagged with eGFP (RV-GFP according to figure 
1B); HP-GFP: HEK293 cells plasmid-tagged with eGFP (P-GFP); CRV-GFP: CHO cells retrovirally tagged with eGFP (RV-GFP); 
CP-AbHTG: CHO cells plasmid- tagged with antibody cassette (PAb-HTG).
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Table 1: Single-copy integration rate of tagged high-expressing 
cells
Retroviral Plasmidal (transfer method)
HEK293 44/48 92% 5/9
(EP Gene Pulser, BioRad)
56%
CHO-K1 2/2 100% 6/20
(Nucleofection, Amaxa)
30%BMC Biotechnology 2009, 9:100 http://www.biomedcentral.com/1472-6750/9/100
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and lack unspecific random integration. In CHO-K1 cells
the targeting efficiency was slightly lower but still above
85%. In some of the successfully targeted CHO-K1 cell
clones we could find additional randomly integrated cop-
ies of the targeting construct.
Homogeneity of expression strength from the targeted cell 
clones
To evaluate the homogeneity of expression level of the
daughter cell clones, three master cell clones were targeted
with expression vectors encoding eGFP, RFP or heavy and
light chains of an antibody. Plasmid-tagged as well as ret-
rovirally tagged clones were chosen and individual daugh-
ter clones were characterized for expression. As illustrated
in Figure 3, CHO-K1 based CP-HTG cells plasmid-tagged
with the eGFP-fusion reporter construct were targeted
with an eGFP (Figure 3C) and an antibody targeting vec-
tor (Figure 3D), respectively. From the analyzed targeted
daughter clones, all showed a pronounced homogeneity
in expression of both reporters which would be expected
from isogenic clones. Accordingly, retrovirally tagged
HEK293 cells (HRV-GFP) were targeted using an RFP cod-
ing vector (Figure 3E) and the RFP expression in the iso-
genic daughter clones again proved to be homogenous.
Finally, an antibody expressing master cell line (CP-
AbHTG) was targeted with an antibody cassette harbour-
ing an expression unit with the same antibody. Again, a
uniform expression pattern within the daughter clones
(lower right). This setting also allowed to compare the
antibody titer of the master cell clone and upon targeting.
Notably, the antibody expression within the daughter
clones (blue) was consistent with that of the parental cell
line (black).
Evaluation of cassette design for antibody expression
To assess the capacity of the tagged integration sites of the
individual master clones to support different cassette
designs and promoters, we designed a set of antibody tar-
geting vectors differing in the architecture. In these target-
ing vectors, the heavy and the light chain genes are either
individually transcribed from SV40 promoter elements or
they are encoded in a bicistronic expression unit driven by
SV40 or MPSV/CMV [23] promoter elements and employ-
ing the NRF [29] or the Poliovirus IRES element [29,30].
In addition, tricistronic expression constructs were created
in which a second IRES element combines the antibody
cassette with the ATG start codon that complements the
defective neomycin resistance gene in the tagging locus
upon targeting.
The mean antibody expression level of the daughter
clones after targeting the indicated vectors in plasmid-
tagged (P) or retrovirally (RV) tagged HEK293 master cells
is shown in Figure 4. Interestingly, in these cells the target-
ing constructs with antibody chains individually control-
led by SV40 promoter elements resulted only in basal
expression levels (0.1-0.1 pcd). This was observed upon
targeting in either of the two transcriptional orientations.
However, upon targeting with the MPSV/CMV driven tri-
cistronic expression cassette the retrovirally tagged clone
yielded 3.4 pcd in the same locus.
We evaluated the same set of antibody expression cas-
settes in two different plasmid-tagged loci in CHO-K1
cells, clones CP-HTG and CP-AbHTG. Figure 5 depicts the
mean antibody expression level of the daughter clones. In
opposite to the tagged HEK293 cells discussed before, all
antibody vectors harbouring two SV40 promoters showed
high expression levels (2.6 - 4.4 pcd). In contrast, in these
integration sites the MPSV/CMV driven expression setup
performed poorly (0.3 pcd). Interestingly, a targeting con-
struct that harbors an SV40 driven bicistronic antibody
expression cassette performed well in CP-AbHTG but
failed in the CP-HTG. Together, these data indicate that
specific regulatory elements are strongly modulated by
flanking chromosomal elements and thus their perform-
ance is critically dependent on the nature of the specific
chromosomal site.
Discussion
High level recombinant protein expression in mamma-
lian cells not only relies on potent transcription promot-
ing elements and optimal design of the expression cassette
but also crucially depends on appropriate chromosomal
sites that support the incoming expression cassette upon
integration. Sophisticated chromosomal engineering
approaches based on site specific recombinases allow the
precise/controlled integration of expression cassettes into
tagged chromosomal sites (reviewed in [17,31,32]). A
first-generation targeting system with a single recombi-
nase target site has recently been evaluated for protein
production. Comparable (consistent) antibody expres-
sion levels could be achieved upon targeting at defined
integration sites in CHO cells using Cre-[33] or Flp-medi-
ated integration [34]. The potential of this technology was
further exploited for the production of a human polyclo-
nal anti-RhD antibody [24] by integrating 25 individual
antibody expression cassettes into a defined FRT tagged
integration site in CHO cells (Flp-In™ cell line; Invitro-
gen). Irrespective of this success first generation targeting
systems are limited by fact that the tagging sequences can-
Table 2: Targeting efficiency and additional random integration
Targeting Random Integration
HRV-GFP 30/30* 100% 0/30 <3%
CP-HTG 48/56* 85,7% 8/56 14,3%
*targeted/neor clonesBMC Biotechnology 2009, 9:100 http://www.biomedcentral.com/1472-6750/9/100
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not be eliminated. Usually, complete vectors including
bacterial sequences are co-integrated which have been
shown to decrease transgene expression from neighboring
promoters (e.g. [35,36]). Also, since excision of the tar-
geted cassette is favored, the targeting efficiency can be
unsatisfactory. In this respect, exchange of tagging cas-
settes via RMCE seems to be the method of choice. While
proof of principle has been given for production of retro-
viral vectors [20,21] so far, a systematic approach evaluat-
ing RMCE for protein production has been missing.
This report describes a comparative approach to identify
potent integration sites that support stable protein pro-
duction and to exploit these sites by Flp RMCE to target
expression cassettes of choice. For this purpose we used
CHO-K1 and HEK293 cells - the most relevant cell lines
for protein production. Motivated by the notion that any
tagging procedure has an intrinsic bias for specific pat-
terns/types of integration sites we employed random tag-
ging strategies based on retroviral or plasmidic transfer of
screening vectors. For monitoring expression we
employed eGFP (either in a single expression unit or in a
fusion to a selection marker) or an IgG molecule. With
these screening approaches we established a set of tagged
master cell lines that stably express the respective reporter
gene(s). Importantly, both plasmidic and retroviral tag-
Gene expression of cell clones after targeting by cassette exchange Figure 3
Gene expression of cell clones after targeting by cassette exchange. Characterization of HP-GFP and CP-GFP upon 
targeting. The cell clones show homogeneous loss of GFP expression after targeting with an antibody expression vector as 
depicted in (B). (B) Molecular characterization of the targeting event by PCR. Amplification of a 550 bp fragment from the 
daughter cell clones (D1-D6) using primers located at the indicated positions (arrows) is specific for integration of the target-
ing construct (P: parental tagged cell clone). (C) Homogeneity of the targeted daughter clones. The expression level of daugh-
ter clones after cassette exchange is compared with the expression level of the parental clones. Upper left: CP-HTG tagged 
clone targeted with a SV40 promoter driven GFP cassette. Upper right: HRV-GFP tagged clone targeted with a CMV-RFP cas-
sette. Antibody targeting: CP-HTG tagged clone (lower left) and CP-AbHTG tagged clone (lower right) were targeted with an 
antibody expression construct as depicted in (B). The expression of the targeted daughter clones is shown.
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
0
1
2
3
4
5
D1 D2 D3 D4 D5 D6
p
c
d
￿
￿
￿
 
!
"
#
$
%
&
’
(
)
*
*
+
￿
,
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
*
￿
-
0
1
2
3
4
5
P D 1D 2D 3D 4D 5
p
c
d
￿
￿
￿
￿
￿
￿
￿
￿
*
￿
-
.
/
0
￿
￿
￿
￿
1
2
3
￿
4
5
6
7
￿
￿
￿
4
5
6
7
8
￿
ѐŶĞŽ
￿
￿
￿
￿
*
-
￿
9
￿
￿
￿
￿
*
-
￿
9
￿
+
+
+
:
;
<
￿
=
￿
,
>
?
+
+
-
+
+
￿
+
+
￿
*
+
+
￿
+
+
￿
￿
￿
@
￿
￿
:
￿
￿
￿
￿
￿
￿
@
￿
￿
:
￿
￿
￿BMC Biotechnology 2009, 9:100 http://www.biomedcentral.com/1472-6750/9/100
Page 9 of 12
(page number not for citation purposes)
ging proved to be appropriate for RMCE since they lead to
a high-percentage of single copy integrants ranging from
30 to > 90% - a prerequisite for targeted integration.
Evaluation of the performance of cassette exchange in the
different master cell clones derived from HEK293 and
CHO-K1 cells using various targeting vectors proved to be
highly efficient with ≥85% correctly targeted daughter
clones. In certain applications, this high efficiency might
overcome the need for subsequent sub-cloning. Further,
analysis of the production levels could confirm that site
directed integration significantly reduces the variations of
clonal expression levels. This is expected from isogenic
clones and is in accordance to previous reports evaluating
this method for production of retroviral vectors [20].
Further, we investigated the flexibility of the tagged inte-
gration sites with respect to supporting other promoters.
Unexpectedly, in the master clones HP-GFP and HRV-GFP
targeting of SV40 based antibody cassettes failed to pro-
vide significant levels of antibody expression (Figure 4).
In contrast, high level antibody expression was obtained
in these integration sites upon targeting either an MPSV/
CMV chimeric promoter or a bidirectional composite pro-
moter, resulting in 3.38 and 1.69 pcd, respectively. Inter-
estingly, the opposite situation was observed in CHO-K1
cell clones: while targeting of the SV40 promoter cassettes
resulted in high level antibody expression in the range of
2.5-4.4 pcd, performance of promoters such as the com-
posite MPSV/CMV and bidirectional AdMLP/pEF promot-
ers was significantly impaired (Figure 5).
Several reports and also results from our lab (e.g. [37];
data not shown) give evidence that the SV40 promoter is
a potent, although not the most favourable promoter in
both CHO and HEK293 cells. This rules out that this dif-
ferential performance obtained upon targeting is a conse-
quence of a diverse set of transcription factors
differentially supporting in these two cell lines. Rather, it
seems to be that the nature/composition of the initial tag-
ging vector would define the capacity of the integration
site with respect to supporting promoters: the master cell
clones HP-GFP and HRV-GFP which were incompatible
with SV40 based targeting vectors were tagged and
screened for high level GFP expression from a PGK pro-
moter and an MSCV promoter, respectively. In contrast,
the master cell clones CP-HTG and CP-ABHTG which
showed high level of SV40 based expression upon target-
ing were initially screened to support an SV40 promoter
driven tagging vector. Together, these data indicate that
Antibody expression after targeting in plasmid-mediated and retrovirally tagged HEK293 Figure 4
Antibody expression after targeting in plasmid-mediated and retrovirally tagged HEK293. The retrovirally (RV) 
or plasmid-mediated (P) tagged GFP expressing HEK293 cells were targeted with the indicated antibody expression cassettes. 
Antibody expression levels are given as mean expression of 5 targeted daughter clones (pcd). n.t.: not tested.
Tagging Reporter Targeting construct
Mean Expression 
(pcd)
RV GFP 0.01-0.1
P GFP 0.01-0.1
RV GFP 0.01-0.1
P GFP 0.01-0.1
RV GFP 3.38 1.4
P GFP n.t.
RV GFP 1.69 0.2
P GFP n.t.
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specific promoters show preferential performances in cer-
tain integration sites.
Our data from the screening for high expression clones
show that chromosomal sites that support high level
expression can be identified with both promoters. How-
ever, it seems that the nature of the integration site specif-
ically defines the final strength of a given promoter. This
interpretation is not immediately compatible with the
general believe that certain promoters are particularly
strong in certain cell lines. It is important to note that the
data that led to this conclusion are derived from transient
expression experiments or from experiments in which
pools of transfectants were analyzed. For transient expres-
sion the composition of soluble (transcription) factors
might indeed constitute the dominant level of promoter
strength [38]. However, upon stable integration into the
host genome the influence of the surrounding chromatin
might be dominant over the influence of the soluble fac-
tors, given that the composition of the promoter allows
expression at all.
This suggests that the strength/potential of a specific inte-
gration site is linked to a certain promoter - and is not nec-
essarily supporting any integrated expression cassette. For
application of the tag-and targeting approach it indicates
that the molecular composition of targeting vectors and
chromosomal integration site go hand-in-hand. Thus, it
will be important to consider the specific requirements of
a particular integration site relating to the maximum level
of recombinant protein production that can be achieved.
Various types of chromosomal elements have been iden-
tified that contribute and modulate individual expression
cassettes upon integration [2-4,39]. In the last years
increasing evidence has been provided showing that not
only specific genetic elements but also complex epigenetic
mechanisms can be involved. We employed RMCE to test
Antibody expression after targeting of plasmid-mediated tagged CHO-K1 Figure 5
Antibody expression after targeting of plasmid-mediated tagged CHO-K1. CHO-K1 derived clones plasmid-medi-
ated tagged with either a HTG or AbHTG cassette as indicated were targeted with different antibody expression cassettes. 
The mean expression of 5 daughter clones after targeting with the depicted constructs as well as the antibody expression of 
the parental cell in pcd is presented. n.t: not tested.
Tagging Reporter
Expression 
(pcd)
Targeting construct
Expression 
(pcd)
P HTG - 2.59 0.27
P AbHTG 2.79 0.15 4.44 0.31
P HTG - 3.87 0.21
P AbHTG 2.79 0.15 2.58 0.35
P HTG - 2.84 0.44
P AbHTG 2.79 0.15 2.64 0.41
PH T G - n.t.
P AbHTG 2.79 0.15 0.30 0.07
P HTG - 0,01-0,1
P AbHTG 2.79 0.15 2.48 0.25
PH T G - n.t.
RV GFP - 0.57 0.06
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if expression from a weak integration site can be increased
by chromosomal engineering of the integration site. How-
ever, neither the cHS4 element nor a potent S/MAR could
significantly (more than 2 fold) increase the level of
expression (data not shown). This indicates that the mere
integration of chromosomal elements into specific loci is
not of benefit per se but would require certain prerequi-
sites. At the same time this gives evidence that our knowl-
edge about the chromosomal elements and their
influence on transgene expression is still rudimental. This
might explain why the rational construction of synthetic
expression domains providing per se all the needs for posi-
tion independent and high expression is not straight for-
ward and is still in its infancy. With the technologies now
available for targeting transgenes to pre-defined loci our
understanding of mechanism governing the crosstalk of
chromosomal elements should be broadened.
Conclusions
RMCE provides a powerful strategy to specifically adapt
vector designs for optimized gene expression to the spe-
cific requirements of chromosomal sites. Thereby, this
method provides a unique tool to exploit such sites for
predictable expression of biotechnologically relevant pro-
teins such as antibodies.
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